Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections

Pharmacological Study of High Doses of Ceftriaxone in Meningitidis

NCT01745679 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

NCT03032380 ·Status: COMPLETED ·Phase: PHASE3

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

NCT00037050 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.

NCT01875263 ·Status: TERMINATED ·Phase: PHASE3

Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

NCT00108433 ·Status: TERMINATED ·Phase: PHASE3

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

NCT00501150 ·Status: COMPLETED ·Phase: NA

A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

NCT06547554 ·Status: COMPLETED ·Phase: PHASE1

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

NCT06738771 ·Status: RECRUITING

Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation

NCT07226557 ·Status: ACTIVE_NOT_RECRUITING

Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis

NCT03681431 ·Status: COMPLETED ·Phase: PHASE2

Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin

NCT00414362 ·Status: COMPLETED

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

NCT02714595 ·Status: COMPLETED ·Phase: PHASE3

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

NCT02439359 ·Status: COMPLETED ·Phase: PHASE1

Comparing Tigecycline Vs. Colistimethate in CNS Infections

NCT06702943 ·Status: NOT_YET_RECRUITING

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 ·Status: COMPLETED ·Phase: PHASE3

Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations

NCT07127185 ·Status: NOT_YET_RECRUITING

Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections

NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit

NCT05171257 ·Status: COMPLETED

Optimising TREATment for Severe Gram-Negative Bacterial Infections

NCT07004049 ·Status: RECRUITING ·Phase: PHASE4

Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).

NCT03481569 ·Status: COMPLETED ·Phase: PHASE1

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

NCT03163446 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.

NCT07247942 ·Status: COMPLETED ·Phase: PHASE1

Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device

NCT04736979 ·Status: COMPLETED

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

NCT05645757 ·Status: COMPLETED ·Phase: PHASE1